C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT
about
Control of the amplification convertase of complement by the plasma protein beta1HFormation and functional significance of a molecular complex derived from the second and the fourth component of human complementComplement system in synovial fluids from patients with rheumatoid arthritis.Neutralization of sensitized virus by purified components of complementProperdin: initiation of alternative complement pathway.Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3Fluid phase destruction of C2hu by C1hu. I. Its enhancement and inhibition by homologous and heterologous C4.Fluid phase destruction of C2hu by C1hu. II. Unmasking by C4ihu of C1hu specificity for C2hu.Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.Studies on the mechanism of solubilization of immune precipitates by serum.Complement components required for virus neutralization by early immunoglobulin antibodyInteractions of the complement system with native and chemically modified endotoxins.Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement systemThe purification and characterization of bovine C4, the fourth component of complement.Enhancement of hemagglutination inhibition by complement.Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis.The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.Fourth component of human complement: description of a three polypeptide chain structure.The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.The isolation and characterization of bovine C4a, an activation fragment of the fourth component of complement.C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.The reaction mechanism of human C5 in immune hemolysis.The binding of human complement component C4 to antibody-antigen aggregates.Conversion of C4 into C4a and C4bConversion of the fourth complement component studied by crossed immunoelectrophoresis.
P2860
Q24561671-87D8A055-336C-4FB9-8D02-DFB697691986Q28610974-FD5675BE-E500-4736-A9C9-6535A25B8B92Q33580015-5F1FDFBB-4A69-4057-90CC-9791F91D3353Q33691527-C706BCAB-0575-47DA-9F59-EFAC809C4769Q35086636-2AB5FDB5-4FE6-4554-8AB5-67B57428898BQ35572234-EA4CC4FF-5F25-48C0-BC75-A647ED4CAE91Q36267933-2DD13A23-9E6A-4DCE-B865-6804B37153BEQ36268183-31D82513-930E-44CF-87A5-10819160D58AQ36268929-21DD43EC-88BA-4BC4-8206-0732B4BA1D6FQ36269627-2A64D93F-ED5B-4015-A319-9AA28BB0D232Q36269993-FD3E688C-165F-42DA-B821-9725A4F8A28CQ36335075-37801BF9-2F70-4121-BF46-50A6C7A63516Q36359108-E29AC2B6-120F-4B12-8AF9-A6246E1CFCD7Q36444928-33670271-E0DD-4002-8911-B5765C10DC29Q36847115-143530A2-8E7B-4059-90C8-FC8035B71966Q37030711-8CBE6EAA-3892-45A6-BCA3-5C2D163E20B4Q37099581-AAC82A1D-5416-422B-BC7C-1C7191FAB8ECQ40711192-D10CC05A-DD92-4DFB-BB55-DAF76AAF03DEQ40899240-3340940B-D002-4418-9372-DB2B0E82E99BQ41548473-9AB89C40-C7CD-4C27-9D16-1D262487BDDBQ41838333-29F9B829-3673-4782-9AC2-DAE3B3752939Q41902314-1A38844F-A21C-4DFB-AA1C-6D96D03855D7Q42154683-2925DEEF-3920-4657-BF9C-E990BBD229F2Q42260495-C364EEA2-0985-4B70-B2AA-B87302C37397Q42821295-E64A1CD7-E495-4EDE-877E-E6F9D7642E5CQ42833165-767782E6-7228-4213-8C9F-EAF2CDB00E07Q42835268-5B1E80BF-A2CA-4152-94A6-9A7BA9D4F138Q42880845-9D490F95-8D77-4D24-9B8A-27DF0D8C8FB4Q50291871-1D6A10EE-5483-482D-90A5-8534CA49B4C3Q53754727-BF2647DB-B036-4DF6-937A-8EE46BD5A168
P2860
C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT
description
1965 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1965 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1965
@ast
im Mai 1965 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1965/05/01)
@sk
vědecký článek publikovaný v roce 1965
@cs
wetenschappelijk artikel (gepubliceerd op 1965/05/01)
@nl
наукова стаття, опублікована в травні 1965
@uk
مقالة علمية (نشرت في مايو 1965)
@ar
name
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@ast
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@en
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@nl
type
label
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@ast
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@en
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@nl
prefLabel
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@ast
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@en
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@nl
P2860
P1476
C'1 ESTERASE EFFECT ON ACTIVIT ...... FOURTH COMPONENT OF COMPLEMENT
@en
P2093
H. J. Mueller-Eberhard
I. H. Lepow
P2860
P304
P407
P577
1965-05-01T00:00:00Z